Toward the development of evidence-based guidelines for the management of methicillin-resistant Staphylococcus aureus otitis

Journal of Otolaryngology - Head and Neck Surgery

Volumn 38, Issue 4, 2009, Pages 483-494

  MacNeil, S Danielle ^a   Westerberg, Brian D ^a,b   Romney, Marc G ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b ST PAUL S HOSPITAL   (Canada)

Author keywords

Methicillin resistant Staphylococcus aureus (MRSA); Otitis externa; Otitis media; Otorrhea

Indexed keywords

CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; PENICILLIN G; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; DISEASE PREDISPOSITION; EVIDENCE BASED MEDICINE; HUMAN; MEDICAL LITERATURE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; OTITIS; OTORRHEA; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; SYSTEMATIC REVIEW;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; EAR; EVIDENCE-BASED MEDICINE; EXUDATES AND TRANSUDATES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; OTITIS; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; URBAN POPULATION; YOUNG ADULT;

EID: 70349241703     PISSN: 19160216     EISSN: None     Source Type: Journal    
DOI: 10.2310/7070.2009.080252     Document Type: Article

References (55)

1. Ayliffe GA. The progressive intercontinental spread of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 1997; 24(Suppl 1):S71.
2. Jevons MP. 'Celbenin'-resistant staphylococci [letter]. Br Med J 1961;1:124.
3. Grundmann H, Ires-de-Sousa M, Boyce J, et al. Emergence and resurgence of methicillin-resistant Staphylococcus aureus as a public-health threat. Lancet 2006;368:874-885 (Pubitemid 44308640)
4. Panlilio AL, Culver DH, Gaynes RP, et al. Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991. Infect Control Hosp Epidemiol 1992;13:582-586
5. Moreno F, Crisp C, Jorgensen JH, et al. Methicillin-resistant Staphylococcus aureus as a community organism. Clin Infect Dis 1995;21:1308-1312
6. Robinson DA, Kearns AM, Holmes A, et al. Re-emergence of early pandemic Staphylococcus aureus as a community-acquired methicillin-resistant clone. Lancet 2005;365:1256-1258 (Pubitemid 40469658)
7. Kazakova SV, Hageman JC, Matava M, et al. A clone of methicillin- resistant Staphylococcus aureus among professional football players. N Engl J Med 2005;352:468-475 (Pubitemid 40175973)
8. Centers for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureus skin or soft tissue infections in a state prison - Mississippi, 2000. MMWR Morb Mortal Wkly Rep 2001;50:919-922
9. Zinderman CE, Conner B, Malakooti MA, et al. Community-acquired methicillin-resistant Staphylococcus aureus among military recruits. Emerg Infect Dis 2004;10:941-944 (Pubitemid 38552772)
10. Haque NZ, Davis SL, Manierski CL, et al. Infective endocarditis caused by USA300 methicillin-resistant Staphylococcus aureus (MRSA). Int J Antimicrob Agents 2007;30:72-77 (Pubitemid 46874896)
11. Tsigrelis C, Armstrong MD, Vlahakis NE, et al. Infective endocarditis due to community-associated methicillin-resistant Staphylococcus aureus in injection drug users may be associated with Panton-Valentine leukocidin-negative strains. Scand J Infect Dis 2007;39:299-302. (Pubitemid 46567379)
12. Sieradzki K, Roberts RB, Haber SW, et al. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection. N Engl J Med 1999;340:517-523 (Pubitemid 29093287)
13. Hwang JH, Tsai HY, Liu TC. Community-acquired methicillin-resistant Staphylococcus aureus infections in discharging ears. Acta Otolaryngol (Stockh) 2002;122:827-830 (Pubitemid 36132452)
14. Suh HK, Jeon YH, Song JS, et al. A molecular epidemiologic study of methicillin-resistant Staphylococcus aureus infection in patients undergoing middle ear surgery. Eur Arch Otorhinolaryngol 1998; 255:347-351
15. Suzuki K, Nishimura T, Baba S. Current status of bacterial resistance in the otolaryngology field: results from the Second Nationwide Survey in Japan. J Infect Chemother 2003;9: 46-52. (Pubitemid 36504370)
16. Gemmell CG, Edwards DI, Fraise AP, et al. Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK. J Antimicrob Chemother 2006;57:589-608.
17. Barton M, Hawkes M, Moore D, et al. Guidelines for the prevention and management of community-associated methicillin-resistant Staphylococcus aureus: a perspective for Canadian health care practitioners. Can J Infect Dis Med Microbiol 2006;17:4C-24C.
18. Ikeda K, Takasaka T. In vitro activity of ototopical drops against middle ear pathogens. Am J Otol 1993;14:170-171.
19. Al-Shawwa BA, Wegner D. Trimethoprim-sulfamethoxazole plus topical antibiotics as therapy for acute otitis media with otorrhea caused by community-acquired methicillin-resistant Staphylococcus aureus in children. Arch Otolaryngol Head Neck Surg 2005;131: 782-784
20. Jang CH, Song CH, Wang PC. Topical vancomycin for chronic suppurative otitis media with methicillin-resistant Staphylococcus aureus otorrhoea. J Laryngol Otol 2004;118:645-647
21. Hwang JH, Chu CK, Liu TC. Changes in bacteriology of discharging ears. J Laryngol Otol 2002;116:686-689
22. Wikler Matthew A. Performance standards for antimicrobial disk susceptibility tests. 9th ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2006.
23. Bauer AW, Kirby WM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 1966;45:493-496
24. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008-2012
25. Sutton AJ, Jones DR, Abrams KR, et al. Systematic reviews and meta-analysis: a structured review of the methodological literature. J Health Serv Res Policy 1999;4:49-55.
26. Moher D, Pham B, Klassen TP, et al. What contributions do languages other than English make on the results of meta-analyses? J Clin Epidemiol 2000;53:964-972
27. Yeo SG, Park DC, Hong SK, et al. Bacteriology of chronic suppurative otitis media-a multicenter study. Acta Otolaryngol (Stockh) 2007;127:1062-1067
28. Park DC, Lee SK, Cha SI, et al. Antimicrobial resistance of Staphylococcus from otorrhea in chronic suppurative otitis media and comparison with results of all isolated staphylococci. Eur J Clin Microbiol Infect Dis 2008;27:571-577
29. Walshe P, Rowley H, Timon C. A worrying development in the microbiology of otitis externa. Clin Otolaryngol Allied Sci 2001;26: 218-220 (Pubitemid 34204395)
30. Mukassabi K. Bacteriology of discharging ears. Irish Med J 2007; 100:379-380
31. Roland PS, Stroman DW. Microbiology of acute otitis externa. Laryngoscope 2002;112:1166-77.
32. Park MK, Jung MH, Kang HJ, et al. The changes of MRSA infections in chronic suppurative otitis media. Otolaryngol Head Neck Surg 2008;139:395-398
33. Gottlieb RD, Shah MK, Perlman DC, et al. Community-acquired methicillin-resistant Staphylococcus aureus infections in otolaryngology. Otolaryngol Head Neck Surg 1992;107:434-437
34. Furukawa M, Minekawa A, Haruyama T, et al. Clinical effectiveness of ototopical application of mupirocin ointment in methicillin-resistant Staphylococcus aureus otorrhea. Otol Neurotol 2008;29:676-678
35. Kayama C, Goto Y, Shimoya S, et al. Effects of gentian violet on refractory discharging ears infected with methicillin-resistant Staphylococcus aureus. J Otolaryngol 2006;35:384-386 (Pubitemid 46064066)
36. Santos F, Mankarious LA, Eavey RD. Methicillin-resistant Staphylococcus aureus: pediatric otitis. Arch Otolaryngol Head Neck Surg 2000;126:1383-1385 (Pubitemid 30842303)
37. Johnigan RH, Pereira KD, Poole MD. Community-acquired methicillin-resistant Staphylococcus aureus in children and adolescents: changing trends. Arch Otolaryngol Head Neck Surg 2003; 129:1049-1052
38. Hartnick CJ, Shott S, Willging JP, et al. Methicillin-resistant Staphylococcus aureus otorrhea after tympanostomy tube placement: an emerging concern. Arch Otolaryngol Head Neck Surg 2000;126:1440-1443
39. Buchalter GM. Near synchronous methicillin-resistant Staphylococcus aureus external auditory canal abscesses in 2 pediatric siblings. Otolaryngol Head Neck Surg 2002;127:238-240
40. Hunt A, Robb PJ. Successful treatment of MRSA otorrhoea: a case report. J Laryngol Otol 2006;120:63-64 (Pubitemid 46832893)
41. Isaacson G, Aronoff SC. Linezolid for tympanostomy tube otorrhea caused by methicillin-resistant Staphylococcus aureus and multiple drug-resistant Streptococcus pneumoniae. Int J Pediatr Otorhinolaryngol 2008;72:647-651
42. Mutoh T, Adachi O, Tsuji K, et al. Efficacy of mastoidectomy on MRSA-infected chronic otitis media with tympanic membrane perforation. Auris Nasus Larynx 2007;34:9-13. (Pubitemid 46136853)
43. Centers for Disease Control and Prevention. Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep 1995;44 (RR-12):1-13.
44. Loeb M, Main C, Walker-Dilks C, et al. Antimicrobial drugs for treating methicillin-resistant Staphylococcus aureus colonization. Cochrane Database Syst Rev 2003;(4):CD003340.
45. Saiman L, Goldfarb J, Kaplan SA, et al. Safety and tolerability of linezolid a pediatric perspective. Pediatr Infect Dis J 2003;22 (9 Suppl):S193-200. (Pubitemid 37158769)
46. Cepeda J, Hayman S, Whitehouse T, et al. Teicoplanin resistance in methicillin-resistant Staphylococcus aureus in an intensive care unit. J Antimicrob Chemother 2003;52:533-534 (Pubitemid 37120749)
47. Coia JE, Duckworth GJ, Edwards DI, et al. Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. J Hosp Infect 2006; 63(Suppl 1):S1-44.
48. Loundon N, Roger G, Vu Thien H, et al. Evolution of the bacteriologic features of persistent acute otitis media compared with acute otitis media: a 15-year study. Arch Otolaryngol Head Neck Surg 1999;125:1134-1140 (Pubitemid 29473378)
49. Amstey MS, Amstey MS. Maternal viral infection with adverse results: cytomegalovirus and herpesvirus. Semin Perinatol 1977;1: 1-10.
50. Ravenscroft JC, Layton A, Barnham M. Observations on high levels of fusidic acid resistant Staphylococcus aureus in Harrogate, North Yorkshire, UK. Clin Exp Dermatol 2000;25:327-330 (Pubitemid 30670593)
51. Patterson WC, Gulick WL. The effects of chloramphenicol upon the electrical activity of the ear. Ann Otol Rhinol Laryngol 1963;72: 50-55
52. Morizono T, Johnstone BM. Ototoxicity of chloramphenicol ear drops with propylene glycol as solvent. Med J Aust 1975;2:634-638
53. Walker S, Diaper CJ, Bowman R, et al. Lack of evidence for systemic toxicity following topical chloramphenicol use. Eye 1998; 12:875-879 (Pubitemid 28482817)
54. Fairbanks DN. Otic topical agents. Otolaryngol Head Neck Surg 1980;88:327-331
55. Tom LW. Ototoxicity of common topical antimycotic preparations. Laryngoscope 2000;110:509-516